Pressure BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 1996
Net Income	-16.82	-34.6	-24.35	-11.66	-9.7	-10.72	-2.71	-7.42	-4.61	-4.08	Upgrade
Depreciation & Amortization	0.12	0.11	0.13	0.12	0.09	0.01	0.02	0.03	0.07	0.08	Upgrade
Share-Based Compensation	0.22	0.25	0.49	1.12	0.59	0.41	0.38	0.21	0.1	0.14	Upgrade
Other Operating Activities	12.01	29.37	18.85	4.09	3.32	6.4	-1.5	3.36	1.24	1.53	Upgrade
Operating Cash Flow	-4.48	-4.87	-4.88	-6.33	-5.7	-3.9	-3.81	-3.82	-3.21	-2.34	Upgrade
Capital Expenditures	-0.02	-0.12	-0	-0.02	0	-0.17	-0.01	-0.01	-0.01	-0.06	Upgrade
Other Investing Activities	-	-	-0.8	-	-	-	-	-	-	-	Upgrade
Investing Cash Flow	-0.02	-0.12	-0.8	-0.02	0	-0.17	-0.01	-0.01	-0.01	-0.06	Upgrade
Dividends Paid	-386.3	-184.27	-299.71	-205.1	-0.44	-0	-0.06	-0.02	-0.08	-0.06	Upgrade
Common Stock Issued	0.03	7,266	255.26	3,275	50.11	0.02	0.53	0.4	0.15	1.43	Upgrade
Share Repurchases	0	-7,081.68	44.45	-3,070	-49.67	0.6	0.06	6.45	0.08	-1.43	Upgrade
Other Financing Activities	390.65	-14,158.25	94.57	-6,133.72	-93.62	4.6	3.43	9.54	3.68	-0.36	Upgrade
Financing Cash Flow	4.37	5.11	5.67	6.28	5.72	4.02	3.83	3.47	3.66	2.43	Upgrade
Net Cash Flow	-0.13	0.11	-0.01	-0.07	0.02	-0.06	0.02	-0.36	0.44	0.03	Upgrade
Free Cash Flow	-4.5	-4.99	-4.88	-6.35	-5.7	-4.08	-3.81	-3.83	-3.22	-2.4	Upgrade
Free Cash Flow Margin	-260.14%	-249.28%	-400.20%	-350.88%	-231.74%	-181.94%	-192.92%	-213.00%	-234.06%	-159.74%	Upgrade
Free Cash Flow Per Share	-0.41	-0.75	-1.48	-3.20	-3.72	-3.66	-4.18	-5.54	-6.77	-6.09	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.